These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7648066)

  • 1. Targeting of bladder cancer with monoclonal antibody NCRC48--a possible approach for intravesical therapy.
    Kunkler RB; Bishop MC; Green DJ; Pimm MV; Price MR; Frier M
    Br J Urol; 1995 Jul; 76(1):81-6. PubMed ID: 7648066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595.
    Hughes OD; Bishop MC; Perkins AC; Wastie ML; Denton G; Price MR; Frier M; Denley H; Rutherford R; Schubiger PA
    J Clin Oncol; 2000 Jan; 18(2):363-70. PubMed ID: 10637251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunolocalization of transitional cell carcinoma of the bladder with intravesically administered technetium-99m labelled HMFG1 monoclonal antibody.
    Malamitsi J; Zorzos J; Varvarigou AD; Archimandritis S; Dassiou C; Skarlos DV; Dimitriou P; Likourinas M; Zizi A; Proukakis C
    Eur J Nucl Med; 1995 Jan; 22(1):25-31. PubMed ID: 7698151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical administration of indium-111-labelled HMFG2 monoclonal antibody in superficial bladder carcinomas.
    Bamias A; Bowles MJ; Krausz T; Williams G; Epenetos AA
    Int J Cancer; 1993 Jul; 54(6):899-903. PubMed ID: 8335396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical administration of radiolabelled tumour-associated monoclonal antibody in bladder cancer.
    Syrigos KN; Khawaja M; Krausz T; Williams G; Epenetos AA
    Acta Oncol; 1999; 38(3):379-82. PubMed ID: 10380831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical administration of radiolabeled antitumor monoclonal antibody in bladder carcinoma.
    Bamias A; Keane P; Krausz T; Williams G; Epenetos AA
    Cancer Res; 1991 Jan; 51(2):724-8. PubMed ID: 1985790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging for staging bladder cancer: a clinical study of intravenous 111indium-labelled anti-MUC1 mucin monoclonal antibody C595.
    Hughes OD; Perkins AC; Frier M; Wastie ML; Denton G; Price MR; Denley H; Bishop MC
    BJU Int; 2001 Jan; 87(1):39-46. PubMed ID: 11121991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoscintigraphy of ovarian carcinoma using a monoclonal antibody (111In-NCRC48) defining a polymorphic epithelial mucin (PEM) epitope.
    Perkins AC; Symonds IM; Pimm MV; Price MR; Wastie ML; Symonds EM
    Nucl Med Commun; 1993 Jul; 14(7):578-86. PubMed ID: 8355918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of copper-67 labelled anti-MUC1 mucin antibody C595 for therapeutic use in bladder cancer.
    Hughes OD; Bishop MC; Perkins AC; Frier M; Price MR; Denton G; Smith A; Rutherford R; Schubiger PA
    Eur J Nucl Med; 1997 Apr; 24(4):439-43. PubMed ID: 9096097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterisation of a C595 antibody-99mTc conjugate for immunoscintigraphy of bladder cancer.
    Simms MS; Murray A; Denton G; Scholfield DP; Price MR; Perkins AC; Bishop MC
    Urol Res; 2001 Feb; 29(1):13-9. PubMed ID: 11310209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor localization and systemic absorption of intravesical instillation of radio-iodinated iododeoxyuridine in patients with bladder cancer.
    Chiou RK; Dalrymple GV; Baranowska-Kortylewicz J; Holdeman KP; Schneiderman MH; Harrison KA; Taylor RJ
    J Urol; 1999 Jul; 162(1):58-62. PubMed ID: 10379740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody.
    Davidson BR; Babich J; Young H; Waddington W; Clarke G; Short M; Boulos P; Styles J; Dean C
    Br J Cancer; 1991 Nov; 64(5):850-6. PubMed ID: 1931605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of 188Re-C595 antibody for radioimmunotherapy of transitional cell bladder cancer.
    Murray A; Simms MS; Scholfield DP; Vincent RM; Denton G; Bishop MC; Price MR; Perkins AC
    J Nucl Med; 2001 May; 42(5):726-32. PubMed ID: 11337567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice.
    Pfost B; Seidl C; Autenrieth M; Saur D; Bruchertseifer F; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
    J Nucl Med; 2009 Oct; 50(10):1700-8. PubMed ID: 19793735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoscintigraphy with iodine-131-labelled monoclonal antibody AUA1 in patients with transitional cell carcinoma of the bladder.
    Zorzos J; Skarlos DV; Pozatzidou P; Zizi A; Bakiras A; Koritsiadis S; Pectasidis D; Koutsioumba P; Epenetos AA; Likourinas M
    Urol Res; 1994; 22(5):323-7. PubMed ID: 7879319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioimmunoimaging of bladder tumor with the intravesical administration of technetium -99m labelled monoclonal antibody].
    Li N; Yu L; Zhang C
    Zhonghua Wai Ke Za Zhi; 1998 Jan; 36(1):54-6. PubMed ID: 11715544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical administration of tumor-associated monoclonal antibody AUA1 in transitional cell carcinoma of the bladder: a study of biodistribution.
    Zorzos J; Skarlos DV; Epenetos AA; Pectasides D; Koutsioumba P; Elemenoglou J; Bakiras A; Likourinas M; Dimopoulos K
    Urol Res; 1993; 21(6):435-8. PubMed ID: 8171767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin expression by transitional cell carcinomas of the bladder.
    Walsh MD; Hohn BG; Thong W; Devine PL; Gardiner RA; Samaratunga ML; McGuckin MA
    Br J Urol; 1994 Mar; 73(3):256-62. PubMed ID: 8162502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.
    Lahorte CM; Bacher K; Burvenich I; Coene ED; Cuvelier C; De Potter C; Thierens H; Van de Wiele C; Dierckx RA; Slegers G
    J Nucl Med; 2004 Jun; 45(6):1065-73. PubMed ID: 15181142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour imaging of bladder carcinomas and their metastases with 111indium-labelled monoclonal anti-CEA antibody BW 431/26.
    Boeckmann W; Baum RP; Schuldes H; Kramer W; Hertel A; Baew-Christow T; Hanke P; Jonas D; Hör G
    Br J Cancer Suppl; 1990 Jul; 10():81-4. PubMed ID: 2383485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.